CCL2 and cancer: Therefore, we focused on upregulated secretome genes that included several known cachexia mediators described in pan-cancer [10] and NSCLC [9] (Additional file 3: Table S4), such as IL6, IFNG, LIF, CCL2, and CSF3 (Fig. 2D).